Media Doctor Canada
Follow us on Twitter








"First Skin Patch Sanctioned for Alzheimer's"


Source: CBC.CA

Published: 09 Jul 2022

Category: Pharmaceutical

Rating: (1½ stars)

what they said (Hover the mouse cursor over underlined words for more info)

WEDNESDAY, July 19 (HealthDay News) - The first patch designed to deliver a widely used Alzheimer's medication via the skin appears to minimize side effects while being easy to use, Swedish researchers say.
"We think we have a new treatment strategy, and it will be very, very much used," said study author Dr. Bengt Winblad, a chief physician in geriatrics medicine at the Karolinska Institutet in Huddinge.....

The original article can be found at:

The original article can found in the Media Doctor archives.

how did it rate? (more information)

Criteria Rating
Total Score 3 of 10
Availability of Treatment Not Satisfactory (?)
Novelty of Treatment Satisfactory (?)
Disease Mongering Satisfactory (?)
Treatment Options Not Satisfactory (?)
Costs of Treatment Not Satisfactory (?)
Evidence Not Satisfactory (?)
Quantification of Benefits of Treatment Not Satisfactory (?)
Harms of Treatment Satisfactory (?)
Sources of Information Not Satisfactory (?)
Relies on Press Release Not Applicable
Quantification of Harms of Treatment Not Satisfactory (?)

what we said (Hover the mouse cursor over underlined words for more info)

This article is about a new method to deliver alzheimer's drugs to patients, through a transdermal system which has just been approved by the U.S. Food and Drug Administration.

While the treatment exists currently in capsule form this article makes the claim that the patch offers 3 times fewer reports of nausea and vomiting. What those original rates of these side effects are, unfortunately not mention.s

This article lacks some information on the topic particularly the nature of the evidence that supported the approval of this drug, and how it might compare to other possible treatments. It also does not mention if this treatment has been approved in Canada and what the cost might be to the patient.

public forum

There are currently no comments on this article.

voice your opinion in the forum

  • All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
  • If you provide your email address it will not be displayed to the general public.
  • Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
  • Required fields are marked with an asterisk (*).
Name: *
Comments: *
Copyright © Media Doctor Canada